Healthcare

Eli Lilly CEO David Ricks is “disappointed” that only one in 10 Americans are on GLP-1s. The company,…

Vince Lahey of Carefree, Arizona, embraces chatbots. From Big Tech products to “shady” ones, they offer “someone that…

After years of frustrating misdiagnoses, a Welsh woman desperately turned to ChatGPT for answers — and the AI…

Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were…

On Thursday, Stormont ministers approved a support package which means that households with a total income of £30,000…

Sheba Medical Center announces that its global health tech innovation arm, ARC, officially launched a startup accelerator yesterday…

AYUN and Omniscope bring predictive immune modeling to Zurich, shifting longevity from snapshots to real-time health tracking. What…

Oral combination therapy boosts lifespan 33% and slows frailty, pointing to a more holistic approach to aging. What…

One goal of human neuroimaging is to illuminate the brain mechanisms that drive cognition and mental health. But…

When Tiffany Davis has a question about a symptom from the weight-loss injections she’s taking, she doesn’t…

In The Pitt, Dr. Robby tells a resident to put up “a force field.” But force fields don’t…

Eli Lilly CEO David Ricks wants more Americans on GLP-1 drugs